Concepedia

Ramy Gadalla

RG

10

Publications

867

Citations

10

H-Index

2017

Active since

Affiliations

Princess Margaret Cancer Centre(Current)

University Health Network

University of Toronto

Cairo University

Ain Shams University

Ramy Gadalla is an author at Princess Margaret Cancer Centre specializing in medicine, immunology, and immunotherapy.

ORCID

Top concepts

Publications per year

2017–2024

10

Publications

10

Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling pathways

Sherif Ibrahim, Ramy Gadalla, Eslam A. Elghonaimy et al. · Molecular Cancer · 2017 · 270 citations · Full text

Validation of CyTOF Against Flow Cytometry for Immunological Studies and Monitoring of Human Cancer Clinical Trials

Ramy Gadalla, Babak Noamani, Bethany MacLeod et al. · Frontiers in Oncology · 2019 · 149 citations · Full text

The transcription factor IRF2 drives interferon-mediated CD8+ T cell exhaustion to restrict anti-tumor immunity

Sabelo Lukhele, Diala Abd Rabbo, Mengdi Guo et al. · Immunity · 2022 · 117 citations · Full text

, , +9

Inflammatory breast cancer: Activation of the aryl hydrocarbon receptor and its target CYP1B1 correlates closely with Wnt5a/b-β-catenin signalling, the stem cell phenotype and disease progression

Hossam Taha Mohamed, Ramy Gadalla, Noura El-Husseiny et al. · Journal of Advanced Research · 2018 · 68 citations · Full text

Translational randomized phase II trial of cabozantinib in combination with nivolumab in advanced, recurrent, or metastatic endometrial cancer

Stéphanie Lheureux, Daniela Matei, Panagiotis A. Konstantinopoulos et al. · Journal for ImmunoTherapy of Cancer · 2022 · 58 citations · Full text

Rows per page

1–5 of 10